SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,476,000 | +2008.6% | 19,800 | +4682.6% | 0.00% | – |
| Q4 2020 | $70,000 | -98.6% | 414 | -98.8% | 0.00% | -100.0% |
| Q3 2020 | $4,978,000 | -82.9% | 35,447 | -80.5% | 0.01% | -84.6% |
| Q2 2020 | $29,128,000 | +114.6% | 181,667 | +30.9% | 0.04% | +77.3% |
| Q1 2020 | $13,571,000 | -74.4% | 138,732 | -66.2% | 0.02% | -70.3% |
| Q4 2019 | $53,032,000 | -68.8% | 410,972 | -81.8% | 0.07% | -71.2% |
| Q3 2019 | $169,841,000 | -36.9% | 2,254,932 | +27.2% | 0.26% | -36.7% |
| Q2 2019 | $269,332,000 | +83.7% | 1,772,504 | +44.1% | 0.41% | +76.5% |
| Q1 2019 | $146,600,000 | -14.4% | 1,229,971 | -21.6% | 0.23% | -24.3% |
| Q4 2018 | $171,210,000 | -40.9% | 1,568,866 | -12.5% | 0.30% | -29.0% |
| Q3 2018 | $289,701,000 | +104.8% | 1,793,701 | +67.6% | 0.43% | +100.9% |
| Q2 2018 | $141,454,000 | – | 1,070,159 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |